OncLive | Bringing the Global Oncology Community Together

The China National Drug Administration has approved alectinib for the treatment of patients with ALK-positive, advanced non–small cell lung cancer. Read More >>

Lead Investigator Discusses Pegilodecakin/PD-1 Inhibitor Combination in NSCLC

Advances Could Lead to Curative Strategies in Myeloma

Expert Navigates Through Expanding Therapeutic Options in NETs

Adequate Resources Are Key to Oncology Clinical Trial Success

Personalized Medicine Continues to Evolve in Oncology

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Dr. Pacheco on Second-Line Therapy for ALK+ NSCLC

Dr. Gentzler on the Role of Chemotherapy in Metastatic NSCLC

Dr. Secord on Using Biomarkers to Guide Treatment Decisions in Ovarian Cancer

Dr. Herzog on the Optimal Use of Bevacizumab in Patients With Ovarian Cancer

Dr. Paulson on When to Consider Lutathera in Patients With NETs

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treating BRAF-Mutated Metastatic Melanoma

EGFR TKIs as Adjuvant Therapy in NSCLC

Metastatic Pancreatic Cancer: Treatment Approaches

Chronic Myeloid Leukemia: Understanding Loss of Response

RAINBOW Study: Antiangiogenic Therapy in Gastric Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

HR+ Breast Cancer: Risk-Stratifying to CDK4/6 Inhibitors

Role of Everolimus in HR+ Metastatic Breast Cancer

Nondriver mNSCLC: Incorporating Trial Data into Practice

VEGF and PD-1 Inhibition in Advanced Gastric/GEJ Cancer

HR+ Breast Cancer: Prognostic Subgroups in MONARCH Trials

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy

Over the past few decades, our knowledge of the role of gene mutations in oncogenesis has transformed cancer care.

View more >>>

Featured

Dr. Wirth on the Use of Lenvatinib in Hypertensive Patients With Thyroid Cancer

Lori J. Wirth, MD, of Massachusetts General Hospital, discusses the use of lenvatinib (Lenvima) in hypertensive patients with thyroid cancer.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More